Open Trial of Duloxetine in Outpatients With Irritable Bowel Syndrome Symptoms and Co-Morbid Major Depression
Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the efficacy of duloxetine in reducing depressive symptoms,
abdominal pain, and other symptoms of Irritable Bowel Syndrome (IRS) in a population of
outpatients with Major Depressive Disorder MDD and clinical symptoms of IBS.